A Prospective Study Comparing the Mifne Approach of Treating Childhood Autism With Routine Standard Treatment
Study Details
Study Description
Brief Summary
The current study aims at comparing outcomes achieved using the Mifne approach of treating autistic children with results obtained when routine standard treatment is used. A prospective comparative study will be performed comparing the results of 12 children treated at Mifne with 12 children treated with treatment as usual. A child and adolescent psychiatrist using the Autism Diagnostic Interview-Revised (ADI-R) and the Autism Diagnostic Observation Schedule-Generic (ADOS-G) will make the diagnostic assessment and a developmental psychologist will make the developmental and psychological assessments using the Vineland Adaptive Behavior Scales-Revised and the Bayley Scales of Infant Development (BSID II) before the child enters the study. Each child will be reassessed following completion of the Mifne intervention, at three and at six months after commencement of treatment. The control child will also be reassessed at three and at six months after commencement of a therapeutic intervention.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Other: A Mifne Approach to PDD |
Behavioral: Mifne Approach to PDD
|
Other: B Treatment as usual |
Behavioral: Treatment as usual
|
Outcome Measures
Primary Outcome Measures
- ADOS scores at 3 and 6 months after commencement of treatment [2.5 years]
Secondary Outcome Measures
- CGI-I score after 3 and 6 months [2.5 years]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
All children between the ages of 2-5 years who meet diagnostic criteria for Autism or Pervasive Developmental Disorder by DSM IV criteria who are referred for treatment at Mifne for the treatment group.
-
The control group will consist of children meeting the same criteria who are referred to Schneider Children's Medical Center of Israel (SCMCI). Matching will be for age, sex, ethnicity, socioeconomic status, IQ, language development and diagnosis.
Exclusion criteria:
- All referred children who do not meet criteria for Autism or PDD or do not understand Hebrew.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Schneider Children's Medical Center of Israel, Departemnt of Psychological Medicine | Petach Tikva | Israel |
Sponsors and Collaborators
- Rabin Medical Center
Investigators
- Principal Investigator: Alan Apter, MD, Director Department of Psychological Medicine Schneider Children's Medical Center of Israel
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 4222